Harnessing the power of combination therapy: reflecting on the final survival data from the CLEAR study with lenvatinib plus pembrolizumab.
作者信息
Shinder Brian M, Meng Lingbin, Singer Eric A
机构信息
Department of Urology, Yale School of Medicine, New Haven, CT, USA.
Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
出版信息
Transl Androl Urol. 2025 Aug 30;14(8):2124-2128. doi: 10.21037/tau-2025-201. Epub 2025 Aug 26.
Abstract
摘要
Zotero 插件